5.12
-0.29 (-5.36%)
-0.29 (-5.36%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.901
High
19.30
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.29 | -5.36% | 5.12 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.52 | 5.05 | 5.52 | 5.09 | 5.41 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.01 | 5.11 | 0.10 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,388 | 225,149 | $ 5.26 | $ 1,185,088 | - | 1.901 - 19.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:28:21 | 4 | $ 5.05 | USD |
Period:
Draw Mode:
Onconova Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 80.80M | 15.78M | 15.71M | $ 231.00k | $ - | -1.95 | -3.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 8.40% |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.42 | 5.74 | 4.75 | 5.31 | 274,069 | -0.30 | -5.54% |
| 1 Month | 7.46 | 7.48 | 4.75 | 6.26 | 409,001 | -2.34 | -31.37% |
| 3 Months | 7.011 | 11.00 | 4.75 | 8.89 | 9,844,694 | -1.89 | -26.97% |
| 6 Months | 7.397 | 19.30 | 4.75 | 11.63 | 26,004,137 | -2.28 | -30.78% |
| 1 Year | 12.70 | 19.30 | 1.901 | 8.68 | 23,647,371 | -7.58 | -59.69% |
| 3 Years | 73.50 | 111.70 | 1.027 | 7.87 | 11,741,993 | -68.38 | -93.03% |
| 5 Years | 675.00 | 676.50 | 1.027 | 11.71 | 7,286,289 | -669.88 | -99.24% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. |
